Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, MI, USA.
Reprod Biomed Online. 2023 Nov;47(5):103323. doi: 10.1016/j.rbmo.2023.103323. Epub 2023 Jul 31.
Are gravidity, parity and breastfeeding history associated with anti-Müllerian hormone concentration among African-American women of reproductive age?
This study included baseline data from the Study of the Environment, Lifestyle and Fibroids, a 5-year longitudinal study of African-American women. Within this community cohort, data from 1392 women aged 25-35 years were analysed. The primary outcome was serum anti-Müllerian hormone concentration measured using the Ansh Labs picoAMH assay, an enzyme-linked immunosorbent assay. Multivariable linear regression models were used to estimate mean differences in anti-Müllerian hormone concentration (β) and 95% CI by self-reported gravidity, parity and breastfeeding history, with adjustment for potential confounders.
Of the 1392 participants, 1063 had a history of gravidity (76.4%). Of these, 891 (83.8%) were parous and 564 had breastfed. Multivariable-adjusted regression analyses found no appreciable difference in anti-Müllerian hormone concentration between nulligravid participants and those with a history of gravidity (β = -0.025, 95% CI -0.145 to 0.094). Among participants with a history of gravidity, there was little difference in anti-Müllerian hormone concentration between parous and nulliparous participants (β = 0.085, 95% CI -0.062 to 0.232). There was also little association between anti-Müllerian hormone concentration and breastfeeding history (ever versus never: β = 0.009, 95% CI -0.093 to 0.111) or duration of breastfeeding (per 1-month increase: β = -0.002, 95% CI -0.010 to 0.006).
Gravidity, parity and breastfeeding history were not meaningfully associated with anti-Müllerian hormone concentration in this large sample of the Study of the Environment, Lifestyle and Fibroids cohort.
生育史、孕次和哺乳史是否与生育年龄的非裔美国女性的抗苗勒管激素浓度有关?
本研究纳入了环境、生活方式和纤维瘤研究(一项针对非裔美国女性的为期 5 年的纵向研究)的基线数据。在这个社区队列中,对 1392 名年龄在 25-35 岁的女性进行了数据分析。主要结局指标是血清抗苗勒管激素浓度,采用 Ansh Labs picoAMH 检测法(酶联免疫吸附试验)进行测量。使用多变量线性回归模型,根据自我报告的生育史、孕次和哺乳史,估计抗苗勒管激素浓度(β)的均值差异及其 95%置信区间,同时调整潜在混杂因素。
在 1392 名参与者中,有 1063 人有生育史(76.4%)。其中,891 人(83.8%)为经产妇,564 人有哺乳史。多变量调整后的回归分析发现,初产妇与有生育史的妇女之间的抗苗勒管激素浓度没有明显差异(β=-0.025,95%CI-0.145 至 0.094)。在有生育史的参与者中,经产妇和初产妇之间的抗苗勒管激素浓度差异很小(β=0.085,95%CI-0.062 至 0.232)。抗苗勒管激素浓度与哺乳史(有 versus 无:β=0.009,95%CI-0.093 至 0.111)或哺乳持续时间(每增加 1 个月:β=-0.002,95%CI-0.010 至 0.006)也没有明显关联。
在这项大型环境、生活方式和纤维瘤研究的研究人群中,生育史、孕次和哺乳史与抗苗勒管激素浓度没有明显关系。